Strong Performance From Downstream Operations Help Drive Earnings for Chevron and Exxon Mobil

Research Driven Investing Provides Stocks Research on Chevron and Exxon Mobil Corporation

Continue Reading

Amyris and Gevo Shares on the Upswing as Environmental Protection Agency Proposes to Raise Renewable Fuels Mandate

Five Star Equities Provides Stock Research on Amyris and Gevo

Continue Reading

FDA Approved a Total of 39 New Drugs in 2012 — Fifteen Year High

Research Driven Investing Provides Stocks Research on Idenix and Orexigen

Continue Reading

Number of FDA Drug Approvals Reach a 15-Year High in 2012

Research Driven Investing Provides Stocks Research on Cleveland BioLabs and Hyperion Therapeutics

Continue Reading

Interest in Gold as a Safe Haven Increases as GDP Contracts for the First Time in 3.5 Years

Five Star Equities Provides Stock Research on IAMGOLD and New Gold

Continue Reading

Environmental Protection Agency Proposes to Increase Renewable Fuels Mandate by 8.9%

Five Star Equities Provides Stock Research on Archer Daniels Midland and Green Plains

Continue Reading

JDS Uniphase and Pitney Bowes Rise on Fourth Quarter Earnings — S&P 500 Index Hovers Near 5-Year Highs

Research Driven Investing Provides Stocks Research on JDS Uniphase and Pitney Bowes

Continue Reading

BioFuel Energy and Pacific Ethanol on the Move as EPA Proposes to Raise Renewable Fuels Mandate

Five Star Equities Provides Stock Research on BioFuel Energy and Pacific Ethanol

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

Research Driven Investing Provides Stocks Research on Achillion and Galena

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

Research Driven Investing Provides Stocks Research on Cell Therapeutics and Dendreon

Continue Reading